iPS cells used to correct genetic mutations that cause muscular dystrophy

The research demonstrates how engineered nucleases, such as TALEN and CRISPR, can be used to edit the genome of iPS cells generated from the skin cells of a DMD patient. The cells were then differentiated into skeletal muscles, in which the mutation responsible for DMD had disappeared.

http://ift.tt/1yfZBeu